Related Experiment Videos
Culture and sensitivity testing of tumors
Texas Medicine
|September 1, 1986
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Resting energy expenditure in adolescents with Down syndrome: a comparison of commonly used predictive equations.
Journal of intellectual disability research : JIDR·2022
Weight status and associated comorbidities in children and adults with Down syndrome, autism spectrum disorder and intellectual and developmental disabilities.
Journal of intellectual disability research : JIDR·2020
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001).
Cancer chemotherapy and pharmacology·2014
Commentary: This Is Not a Drill.
Texas medicine·2021
Talk to Patients About: Vaccine Adverse Event Reporting System (VAERS).
Texas medicine·2021
Obstacles to Clear.
Texas medicine·2021